This case underscores the potential of the tyrosine kinase inhibitor alectinib to cause severe grade 4 renal toxicity, which was reversible in this patient with metastatic lung cancer.
Journal of Medical Case Reports
Original Article: Alectinib-induced Reversible Grade IV Nephrotoxicity